Gingko Biloba : Practical Management of Adverse Effects and Drug Interactions

Ernst E. The risk-benefit profile of commonly used herbal therapies: gingko, St. John's wort, ginseng, echinacea, saw palmetto and kava. Ann Intern Med 2002; 136 (1): 42–53

Zeng X Liu M Yang Y Gingko biloba for acute ischemic stroke. Cochrane Database Syst Rev 2005; 19 (4): CD003691

Natural medicines monograph. Gingko biloba. Natural Medicines Comprehensive Database 2006. Available: www.naturaldatabase.com (accessed May 2006)

Evans JR. Gingko biloba for age-related macular degeneration. Cochrane Database Syst Rev 2000;(2): CD001775

Wheatley D. Triple-blind, placebo-controlled trial of Gingko biloba in sexual dysfunction due to antidepressant drugs. Hum Psychopharmacol 2004; 19 (8): 545–48

Hilton M Stuart E. Gingko biloba for tinnitus. Cochrane Database Syst Rev 2004;(2): CD003852

Pittler MH Ernst E. Gingko biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med 2000; 108 (4): 276–81

Birks J Grimley EV Van Dongen M. Gingko biloba for cognitive impairment and dementia. Cochrane Database Syst Rev 2002;(4): CD003120

Schneider LS DeKosky ST Farlow MR A randomized, double-blind, placebo-controlled trial of two doses of Gingko biloba extract in dementia of the Alzheimer's type. Curr Alzheimer Res 2005; 2 (5): 495–6

Mix JA Crews WD Jr. A double-blind, placebo-controlled, randomized trial of Gingko biloba extract Egb 761 in a sample of cognitively intact older adults: neuropsychological findings. Hum Psychopharmacol 2002; 17 (6): 267–77

Solomon PR Adams F Silver A Gingko for memory enhancement: a randomized controlled trial. JAMA 2002; 288 (7): 835–40

Quaranta L Bettelli S Uva MG Effect of Gingko biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology 2003; 110 (2): 359–62

Burrowes JD Van Houten G. Herbs and dietary supplement use in patients with stage 5 chronic kidney disease. Nephrol Nurs J 2006; 33 (1): 85–6

Bent S Goldberg H Padula A Avins AL. Spontaneous bleeding associated with Gingko biloba: a case report and systematic review of the literature. J Gen Intern Med 2005; 20 (7): 657–61

Bebbington A Kulkarni R Roberts P. Ginkgo biloba: persistent bleeding after total hip arthroplasty caused by herbal self-medication. J Arthroplasty 2005; 20 (1): 125–6

Kim SH Lee EK Chang JW Effects of Gingko biloba on haemostatic factors and inflammation in chronic peritoneal dialysis patients. Phytother Res 2005; 19 (6): 546–8

Yagmur E Piatkowski A Groger A Bleeding complication under Gingko biloba medication. Am J Hematol 2005; 79 (4): 343–4

Mills E Wu P Johnston BC Natural health product—drug interactions: a systematic review of clinical trials. Ther Drug Monit 2005; 27 (5): 549–57

Kupiec T Vishnu R. Fatal seizures due to potential herb-drug interactions with Gingko biloba. J Anal Toxicol 2005; 29 (7): 755–8

Granger AS. Gingko biloba precipitating epileptic seizures. Age Ageing 2001; 30 (6): 523–5

Shannon M McElroy E Anderson Liebelt EL. Toxic seizures in children: case scenarios and treatment strategies. Pediatr Emerg Care 2003; 19 (3): 206–10

He N Edeki T. The inhibitory effects of herbal components on CYP2C9 and CYP3A4 catalytic activities in human liver microsomes. Am J Ther 2004; 11 (3): 206–12

Von Moltke LL Weemhoff JL Bedir E Inhibition of human cytochromes P450 by components of Gingko biloba. J Pharm Pharmacol 2004; 56 (8): 1039–44

Gaudineau C Beckerman R Welbourn S Auclair K. Inhibition of human P450 enzymes by multiple constituents of the Gingko biloba extract. Biochem Biophys Res Commun 2004; 318 (4): 1072–8

Yin OQ Tomlinson B Wave MM Pharmacogenetics and herb-drug interactions: experience with Gingko biloba and omeprazole. Pharmacogenetics 2004; 14 (12): 841–50

Yasui-Furukori N Furukori H Kaneda A The effects of Gingko biloba on the pharmacokinetics and pharmacodynamics of donepezil. J Clin Pharmacol 2004:44 (5): 538–42

Fowler JS Wang GJ Volkow ND Logan J Franceschi D Franceschi M Evidence that Gingko biloba extract does not inhibit MAO A and B in human living brain. Life Sci 2000; 66 (9): PL141–6

Sloley BD. Identification of kaempferol as a monoamine oxidase inhibitor. J Pharm Pharmacol 2000; 52 (4): 451–9

Kajiyama Y Fujii K Takeuchi H Manabe Y. Gingko seed poisoning. Pediatrics 2002; 109 (2): 325–7

Kudolo GB. The effect of 3-month ingestion of Gingko biloba extract (Egb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus. J Clin Pharmacol 2001; 41 (6): 600–11

Kudolo GB Wang W Elrod R Short-term ingestion of Gingko biloba extract does not alter whole body insulin sensitivity in non-diabetic, pre-diabetic or type 2 diabetic subjects — a randomized double-blind placebo-controlled crossover study. Clin Nutr 2006; 25 (1): 123–34

Chandler F editor. Herbs: everyday reference for health professionals. Ottawa: Canadian Pharmacists Association; 2000